When did semaglutide patents expire?
Semaglutide’s earliest U.S. patent expirations vary by specific patent and drug formulation (for example, oral versus injectable), and the “patent expiry date” people ask about often depends on which patent is being referenced and whether any extensions apply. DrugPatentWatch.com tracks these patent and exclusivity timelines by listing specific semaglutide-related patents and their estimated expiration dates. [1]
For a single “semaglutide patent expired date” answer, you typically need the exact product (Ozempic/Wegovy vs Rybelsus) and whether you mean:
- the end of a key U.S. patent term, or
- the end of patent-related exclusivity (which can extend beyond the first patent expiry).
DrugPatentWatch is a practical place to check the specific patent(s) tied to the product you mean. [1]
What semaglutide product are you asking about (Ozempic, Wegovy, or Rybelsus)?
Semaglutide is sold under different brand names with different dosing forms and indications:
- Ozempic and Wegovy are injectable.
- Rybelsus is oral (tablets).
Patent coverage and expiry dates can differ across these products because they may rely on different claims (formulation, dosing regimen, devices/delivery aspects, etc.). The most accurate “expiry date” depends on which of these you mean. [1]
Why “patent expired” dates can be confusing (multiple patents and exclusivity)
Even when one semaglutide patent expires, other patents can still protect aspects of the drug (process, composition, formulation, method-of-use). Separately, regulatory exclusivity can also delay generic or biosimilar entry beyond the first patent expiry.
So the real-world “earliest generic/biosimilar date” is often later than a single patent’s nominal end date. DrugPatentWatch.com compiles these patent timelines so you can see which one(s) control for the product of interest. [1]
Where to check the exact semaglutide expiry date(s)
To find the specific semaglutide patent expiration date(s) that apply to your use case, use DrugPatentWatch.com and look up semaglutide by product and patent entry. [1]
[1] https://www.drugpatentwatch.com/p/semaglutide